Aller au contenu principal
Fermer
  2. Aide
  2. Aide

New strategic Milestone for Biophytis: Official Establishment of Its Joint Venture in Asia
information fournie par Boursorama CP 09/06/2026 à 07:00
Ajoutez Boursorama à vos sources préférées

Paris (France) and Cambridge (Massachusetts, United States), June 9th, 2026 at 7.00 AM (CET) –
Biophytis SA (Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a pioneer in the development of transformative therapies impacting longevity, today announces the official registration of its joint venture in Hong Kong, Biophytis Biopharmaceutical Group Limited, marking a decisive milestone in the implementation of the strategic partnership in Asia, which was announced on January 28, 2026.
This new entity represents a major step in Biophytis’ international strategy to strengthen its presence in Asia. It will be tasked with developing and commercializing BIO101 in the region, particularly for the treatment of sarcopenia.

Valeurs associées

BIOPHYTIS
0,0153 EUR Euronext Paris 0,00%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

valeur

dernier

var.
Pétrole Brent
96,89 -4,11%
CAC 40
8 372,28 +0,88%
2CRSI
27,58 +4,08%
TOTALENERGIES
75,9 -0,37%
SOITEC
115,25 -1,33%
Chargement...

Pages les plus populaires

L'offre BoursoBank